Press release
Pleural Effusion Treatment Device Market Projected to Reach USD 650 Million by 2034
Pleural Effusion Treatment Device
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71517
In recent years, advances in minimally invasive procedures, the adoption of indwelling pleural catheters, and improved diagnostic technologies have transformed patient management. From 2024 to 2034, the pleural effusion treatment device market is projected to witness strong growth, supported by the expansion of palliative care, technological innovation, and rising healthcare investments worldwide.
Market Overview
The global pleural effusion treatment device market size is estimated at USD 350 Million in 2024 and is projected to reach USD 650 Million by 2034, growing at a CAGR of 7.2% during the forecast period.
Key highlights:
• Increasing incidence of pleural effusion associated with malignancies and cardiovascular diseases.
• Growing adoption of indwelling pleural catheters (IPCs) for long-term outpatient management.
• Rising preference for minimally invasive procedures over surgical interventions.
• Strong demand for homecare-based drainage solutions.
• North America and Europe lead in adoption, while Asia-Pacific is expected to record the fastest growth.
Market Segmentation
By Product
• Indwelling Pleural Catheters (IPCs)
• Pleurodesis Agents (Talc, Others)
• Thoracentesis Kits
• Drainage Systems & Bottles
• Others
By Technology
• Minimally Invasive Drainage Procedures
• Chemical Pleurodesis
• Surgical Interventions
• Smart/Digital Drainage Systems
By Platform
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End Use
• Hospitals & Specialty Clinics
• Ambulatory Care Centers
• Homecare Settings
By Application
• Malignant Pleural Effusion (MPE)
• Congestive Heart Failure-Associated Effusion
• Infectious Diseases (Pneumonia, Tuberculosis)
• Other Conditions
Summary of Segmentation
Indwelling pleural catheters dominate the market due to their growing use in both hospital and homecare settings, offering patients a safe and effective long-term management option. Pleurodesis agents remain widely used for permanent resolution of recurrent effusion, while smart drainage systems represent the next frontier in patient monitoring.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71517/pleural-effusion-treatment-device-market
Regional Analysis
North America
• Largest market in 2024 due to advanced healthcare infrastructure, high prevalence of cancer and cardiac diseases, and strong adoption of IPCs.
• Supportive reimbursement systems and clinical trial activity fuel growth.
Europe
• Second-largest market, led by Germany, the UK, France, and Italy.
• Strong uptake of pleurodesis procedures and indwelling catheters in oncology care.
Asia-Pacific
• Fastest-growing region during 2024-2034.
• Rising burden of tuberculosis and lung cancer in China, India, and Southeast Asia.
• Expansion of tertiary hospitals and growing demand for cost-effective treatment devices.
Middle East & Africa
• Gradual growth with increasing healthcare investments and adoption of minimally invasive drainage solutions.
Latin America
• Brazil and Mexico dominate the region with growing availability of pleural effusion management in public hospitals.
Regional Summary
North America and Europe continue to dominate, but Asia-Pacific will see the highest growth rate, supported by its large patient base and improving healthcare access.
Market Dynamics
Growth Drivers
• Rising global prevalence of cancer, tuberculosis, and chronic heart failure.
• Increased adoption of minimally invasive and home-based treatment options.
• Technological innovations in smart drainage and indwelling catheter systems.
• Growing awareness and palliative care initiatives worldwide.
Key Challenges
• High cost of advanced devices in emerging markets.
• Risk of complications such as infections and catheter blockages.
• Limited awareness and late diagnosis in low-income countries.
Latest Trends
• Smart pleural drainage systems with digital monitoring for fluid volume and pressure.
• Expanding use of homecare-based IPCs for patient convenience.
• Integration of telehealth in follow-up care for pleural effusion patients.
• Clinical research into combining pleurodesis with oncology therapies for better outcomes.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71517
Competitive Landscape
Major Players
• Becton, Dickinson and Company (BD)
• Boston Scientific Corporation
• Teleflex Incorporated
• Merit Medical Systems, Inc.
• Cook Medical
• Rocket Medical plc
• Smiths Medical
• AngioDynamics Inc.
• Cardinal Health Inc.
• Medtronic plc
• Olympus Corporation
• Novatech SA
Competition Summary
The market is moderately consolidated, with BD, Boston Scientific, and Teleflex holding strong positions through their comprehensive portfolios of IPCs and drainage devices. Regional players are gaining traction in emerging economies with cost-effective solutions. Partnerships, product launches, and acquisitions remain the key strategies driving competitive advantage.
Conclusion
The pleural effusion treatment device market is positioned for steady expansion, driven by the rising prevalence of cancer, tuberculosis, and heart disease. With innovations in indwelling catheters, pleurodesis agents, and digital drainage systems, patient care is becoming more effective and accessible.
Despite barriers such as high device costs and infection risks, the market offers significant opportunities in emerging regions and through integration of smart monitoring solutions. For manufacturers, healthcare providers, and investors, this segment presents strong growth potential through 2034.
Key Takeaways:
• Indwelling pleural catheters dominate but smart drainage systems are the future.
• North America and Europe lead today, but Asia-Pacific is set to grow fastest.
• Innovation, affordability, and partnerships will define long-term competitive advantage.
This report is also available in the following languages : Japanese (胸水治療装置市場), Korean (흉막 삼출액 치료 장치 시장), Chinese (胸腔积液治疗设备市场), French (Marché des dispositifs de traitement de l'épanchement pleural), German (Markt für Geräte zur Behandlung von Pleuraergüssen), and Italian (Mercato dei dispositivi per il trattamento dell'effusione pleurica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71517/pleural-effusion-treatment-device-market#request-a-sample
Our More Reports:
Focal Epilepsy Market
https://exactitudeconsultancy.com/reports/71938/focal-epilepsy-market
Horners Syndrome Market
https://exactitudeconsultancy.com/reports/71939/horners-syndrome-market
Hypersomnia Market
https://exactitudeconsultancy.com/reports/71940/hypersomnia-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleural Effusion Treatment Device Market Projected to Reach USD 650 Million by 2034 here
News-ID: 4170319 • Views: …
More Releases from Exactitude Consultancy
SSG Hospital launches an AI-powered oncology chatbot
The global AI in Oncology Market is rapidly emerging as one of the most transformative frontiers in healthcare, combining advanced machine learning, big data analytics, and clinical expertise to fight cancer. With oncology representing one of the most complex medical domains, artificial intelligence (AI) is reshaping how clinicians detect, diagnose, and treat cancer. AI is accelerating drug discovery, enhancing diagnostic imaging, enabling personalized treatment recommendations, and improving patient monitoring. As…
Orion and Abilita Therapeutics Announce Research Partnership to Create Next-Gene …
The global Next-Generation Antibody Therapeutics Market is experiencing rapid growth as pharmaceutical and biotechnology companies push the boundaries of antibody engineering to deliver safer, more effective, and highly targeted therapies. Unlike conventional monoclonal antibodies, next-generation formats-such as bispecific antibodies, antibody-drug conjugates (ADCs), antibody fragments, and engineered scaffolds-offer enhanced specificity, improved pharmacokinetics, and novel mechanisms of action. These innovations are revolutionizing treatment landscapes in oncology, autoimmune disorders, infectious diseases, and rare…
Prospects for the NAMPT Inhibitors Market in 2025-2034 | Pfizer Inc., Novartis A …
The NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitor Market is gaining momentum as researchers and biopharmaceutical companies explore novel therapeutic strategies targeting cellular metabolism and inflammatory pathways. NAMPT, a key enzyme in the NAD+ biosynthesis pathway, has been implicated in cancer cell survival, immune regulation, and metabolic disorders. Inhibitors of NAMPT have emerged as promising candidates for oncology, autoimmune conditions, and age-related diseases. With clinical trials expanding and increasing R&D investments, the NAMPT…
Acute lymphoblastic leukemia: a comprehensive review and 2025 latest update
Introduction
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the blood and bone marrow that primarily affects white blood cell precursors. While relatively rare compared to other cancers, it is the most common type of cancer in children, though it also affects adults, where prognosis is often poorer.
The management of ALL has improved significantly in recent decades due to advances in chemotherapy regimens, targeted therapies, and immunotherapies such as CAR-T…
More Releases for Pleural
Pleural Effusion Market Emerging Trends and Growth Prospects 2034
Introduction
Pleural effusion, a condition characterized by the accumulation of excess fluid in the pleural cavity, often results from underlying diseases such as malignant tumors, heart failure, and infections. This condition can significantly impair respiratory function and lead to symptoms like shortness of breath, chest pain, and coughing. The global burden of pleural effusion is rising, particularly due to the increasing prevalence of lung cancer, heart disease, and chronic respiratory diseases.
The…
Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …
DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Malignant Pleural Effusion Research.…
Pleural Drainage Catheters Market Size 2024 to 2031.
Market Overview and Report Coverage
A Pleural Drainage Catheter is a medical device used to drain fluid or air from the pleural cavity surrounding the lungs. These catheters are commonly used in patients suffering from conditions such as pneumonia, lung cancer, or pleural effusion.
The Pleural Drainage Catheters Market is expected to witness significant growth in the coming years, with a projected CAGR of 7.80% during the forecasted period. This…
Pleural Drainage Catheters Market Will Generate Record Revenue by 2031
Pleural Drainage Catheters Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.88% from 2024 to 2030. The Pleural Drainage Catheters Market is witnessing a significant surge, driven by a myriad of factors including the rising prevalence of respiratory disorders, advancements in catheter technology, and increasing demand for minimally invasive treatment options. This article explores the latest…
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
The pleural effusion drug market is expected to gain market growth at a potential rate of 4.70% in the forecast period of 2021 to 2028. Increase in prevalence rate of pleural effusion worldwide is the vital factor escalating the pleural effusion drug market growth.
Pleural effusion is a type of condition in which excessive fluids build-up or accumulates in the…
Malignant Pleural Effusions to Gain Maximum Traction in Pleural Catheters Market …
250 Pages Pleural Catheters Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR’s recent market research, sales of Pleural Catheters to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus on…
